Molecular Basis of Antiretroviral Drugs-Associated Long-Term Toxicity: How Bad can Good Drugs Be?

E-ISSN： 1875-600x|3|2|109-133

ISSN： 1568-0126

Source： Current Medicinal Chemistry - Anti-Infective Agents, Vol.3, Iss.2, 2004-06, pp. : 109-133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Consequences of Drugs on the Paediatric Cardiovascular System

By Hausner Elizabeth Fiszman Monica L. Hanig Joseph Harlow Patricia Zornberg Gwen Sobel Solomon

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1083-1096

Adis International

Access to resources Recommend Favorite

Short- and long-term safety of glaucoma drugs

By Schuman Joel S

Expert Opinion on Drug Safety, Vol. 1, Iss. 2, 2002-07 ,pp. : 181-194

Informa Healthcare

Access to resources Recommend Favorite

Impact of Mitochondrial Toxicity of HIV-1 Antiretroviral Drugs on Lipodystrophy and Metabolic Dysregulation

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3339-3351

Bentham Science Publishers

Access to resources Recommend Favorite

Proof of principle: antiretroviral drugs can prevent sexual transmission of HIV-1

By Wainberg Mark A Field Hugh J

Future Virology, Vol. 6, Iss. 5, 2011-05 ,pp. : 549-551

Future Medicine

Access to resources Recommend Favorite

Use of behavioural and long-term potentiation models in the development of memory-improving drugs

By Blokland Arjan Boess Frank

Expert Opinion on Drug Discovery, Vol. 3, Iss. 9, 2008-09 ,pp. : 1067-1080

Informa Healthcare

Access to resources Recommend Favorite